Awarded: Jul 01, 2018
$495,000 over 3 years
In 2018, 18 physician scientists received three-year grants of $495,000 each to support their transition to independent clinical research careers.
2018 CSDA Grantees
Collin M. Blakely, M.D., Ph.D. (Doris Duke-Damon Runyon Clincal Investigators)
University of California San Francisco
Project name: Mechanisms of incomplete response and primary resistance to osimertinib in EGFR-mutant lung cancer
Melanie Cree-Green, M.D., Ph.D.
University of Colorado
Project name: Use of essential amino acid supplementation to decrease metabolic disease in high risk obese girls with polycystic ovarian syndrome
Jianjun Gao, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Project name: A biomarker-based, combination therapy with immune checkpoint blockade and pemetrexed for MTAP-deficient metastatic bladder cancer
Jacqueline M. Garonzik Wang, M.D., Ph.D.
Johns Hopkins University
Project name: Quantifying the risk and survival benefit of incompatible live donor kidney transplantation in the modern era
Brice Gaudilliere, M.D., Ph.D.
Stanford University
Project name: Immune Sensors of Preterm Labor: A Systems Immunology Analysis with Mass Cytometry
Jonathan A. Kropski, M.D.
Vanderbilt University Medical Center
Project name: Mechanisms of disease initiation and propagation in pulmonary fibrosis
Christin S. Kuo, M.D.
Stanford University
Project name: Pulmonary neuroendocrine cell signaling in the developing lung and in disease
Carolyn S. Lee, M.D., Ph.D.
Stanford University
Project name: Regulators of Skin Cancer Progression
Peggy S. Myung, M.D., Ph.D.
Yale University
Project name: Dissecting the epithelial-mesenchymal interactions at the interface of the human skin regeneration and cancer
Karen C. Nanji, M.D., M.P.H.
Massachusetts General Hospital
Project name: Preventing Perioperative Medication Errors Through the Reduction of Clinical Decision Support Alert Overrides
Eileen P. Scully, M.D., Ph.D.
Johns Hopkins University
Project name: Defining mechanisms of innate immune programming and dysfunction in HIV disease
Ashley H. Shoemaker, M.D., M.S.C.I
Vanderbilt University Medical Center
Project name: Phase 2 study of theophylline for the treatment of pseudohypoparathyroidism
David H. Spencer, M.D., Ph.D.
Washington University
Project name: Identifying epigenetic drivers in acute myeloid leukemia
Matthew D. Stachler, M.D., Ph.D.
Brigham and Women’s Hospital
Project name: Genomic determinants and biomarkers of Barrett’s esophagus progression
Ramnath Subbaraman, M.D., M.Sc.
Tufts University
Project name: Finding and retaining India’s “missing” tuberculosis patients: informing large-scale active case-finding strategies through analyses of the case cascade and geospatial mapping
Tuan M. Tran, M.D., Ph.D.
Indiana University
Project name: Systems analysis to understand protective immunity induced by an attenuated sporozoite malaria vaccine in African infants
Kevin C. Wang, M.D., Ph.D.
Stanford University
Project name: Epigenetic Modulation of Chromatin Architecture in Human Fibroblasts as a Novel Therapeutic Approach for Wound Healing and Regeneration
Jennifer A. Woo Baidal, M.D., M.P.H
Columbia University
Project name: Developing novel clinical approaches to reduce childhood obesity risk factors during the first 1,000 days